HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?

Universal HIV testing and immediate antiretroviral therapy for infected individuals has been proposed as a way of reducing the transmission of HIV and thereby bringing the HIV epidemic under control. It is unclear whether transmission during early HIV infection—before individuals are likely to have...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Myron S., Dye, Christopher, Fraser, Christophe, Miller, William C., Powers, Kimberly A., Williams, Brian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393667/
https://www.ncbi.nlm.nih.gov/pubmed/22802728
http://dx.doi.org/10.1371/journal.pmed.1001232
_version_ 1782237745447436288
author Cohen, Myron S.
Dye, Christopher
Fraser, Christophe
Miller, William C.
Powers, Kimberly A.
Williams, Brian G.
author_facet Cohen, Myron S.
Dye, Christopher
Fraser, Christophe
Miller, William C.
Powers, Kimberly A.
Williams, Brian G.
author_sort Cohen, Myron S.
collection PubMed
description Universal HIV testing and immediate antiretroviral therapy for infected individuals has been proposed as a way of reducing the transmission of HIV and thereby bringing the HIV epidemic under control. It is unclear whether transmission during early HIV infection—before individuals are likely to have been diagnosed with HIV and started on antiretroviral therapy—will compromise the effectiveness of treatment as prevention. This article presents two opposing viewpoints by Powers, Miller, and Cohen, and Williams and Dye, followed by a commentary by Fraser.
format Online
Article
Text
id pubmed-3393667
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33936672012-07-16 HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies? Cohen, Myron S. Dye, Christopher Fraser, Christophe Miller, William C. Powers, Kimberly A. Williams, Brian G. PLoS Med Review Universal HIV testing and immediate antiretroviral therapy for infected individuals has been proposed as a way of reducing the transmission of HIV and thereby bringing the HIV epidemic under control. It is unclear whether transmission during early HIV infection—before individuals are likely to have been diagnosed with HIV and started on antiretroviral therapy—will compromise the effectiveness of treatment as prevention. This article presents two opposing viewpoints by Powers, Miller, and Cohen, and Williams and Dye, followed by a commentary by Fraser. Public Library of Science 2012-07-10 /pmc/articles/PMC3393667/ /pubmed/22802728 http://dx.doi.org/10.1371/journal.pmed.1001232 Text en Cohen et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Review
Cohen, Myron S.
Dye, Christopher
Fraser, Christophe
Miller, William C.
Powers, Kimberly A.
Williams, Brian G.
HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
title HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
title_full HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
title_fullStr HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
title_full_unstemmed HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
title_short HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
title_sort hiv treatment as prevention: debate and commentary—will early infection compromise treatment-as-prevention strategies?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393667/
https://www.ncbi.nlm.nih.gov/pubmed/22802728
http://dx.doi.org/10.1371/journal.pmed.1001232
work_keys_str_mv AT cohenmyrons hivtreatmentaspreventiondebateandcommentarywillearlyinfectioncompromisetreatmentaspreventionstrategies
AT dyechristopher hivtreatmentaspreventiondebateandcommentarywillearlyinfectioncompromisetreatmentaspreventionstrategies
AT fraserchristophe hivtreatmentaspreventiondebateandcommentarywillearlyinfectioncompromisetreatmentaspreventionstrategies
AT millerwilliamc hivtreatmentaspreventiondebateandcommentarywillearlyinfectioncompromisetreatmentaspreventionstrategies
AT powerskimberlya hivtreatmentaspreventiondebateandcommentarywillearlyinfectioncompromisetreatmentaspreventionstrategies
AT williamsbriang hivtreatmentaspreventiondebateandcommentarywillearlyinfectioncompromisetreatmentaspreventionstrategies

Ejemplares similares